Correlation Between Bouygues and Maat Pharma
Can any of the company-specific risk be diversified away by investing in both Bouygues and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bouygues and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bouygues SA and Maat Pharma SA, you can compare the effects of market volatilities on Bouygues and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bouygues with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bouygues and Maat Pharma.
Diversification Opportunities for Bouygues and Maat Pharma
-0.93 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bouygues and Maat is -0.93. Overlapping area represents the amount of risk that can be diversified away by holding Bouygues SA and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Bouygues is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bouygues SA are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Bouygues i.e., Bouygues and Maat Pharma go up and down completely randomly.
Pair Corralation between Bouygues and Maat Pharma
Assuming the 90 days horizon Bouygues SA is expected to generate 0.33 times more return on investment than Maat Pharma. However, Bouygues SA is 3.04 times less risky than Maat Pharma. It trades about 0.37 of its potential returns per unit of risk. Maat Pharma SA is currently generating about -0.11 per unit of risk. If you would invest 2,854 in Bouygues SA on December 30, 2024 and sell it today you would earn a total of 837.00 from holding Bouygues SA or generate 29.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Bouygues SA vs. Maat Pharma SA
Performance |
Timeline |
Bouygues SA |
Maat Pharma SA |
Bouygues and Maat Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bouygues and Maat Pharma
The main advantage of trading using opposite Bouygues and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bouygues position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.Bouygues vs. Vinci SA | Bouygues vs. Compagnie de Saint Gobain | Bouygues vs. Orange SA | Bouygues vs. Veolia Environnement VE |
Maat Pharma vs. OSE Pharma SA | Maat Pharma vs. Abivax SA | Maat Pharma vs. Waga Energy SA | Maat Pharma vs. Inventiva SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |